Halozyme Therapeutics shares owned by Foresight Capital Management Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Foresight Capital Management Advisors
from 13F filings
Historical chart of Foresight Capital Management Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Foresight Capital Management Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Foresight Capital Management Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $35k | 30k | 1.16 |
| 2025-06-30 | $30k | 30k | 0.99 |
| 2025-03-31 | $37k | 35k | 1.05 |
| 2024-12-31 | $33k | 35k | 0.95 |
| 2024-09-30 | $39k | 39k | 1.00 |
| 2024-06-30 | $42k | 44k | 0.95 |
| 2024-03-31 | $39k | 44k | 0.89 |
| 2023-12-31 | $38k | 44k | 0.86 |
| 2022-09-30 | $30k | 35k | 0.86 |
| 2022-06-30 | $31k | 35k | 0.89 |
More positions owned by Foresight Capital Management Advisors
View all positions for Foresight Capital Management Advisors